Toxicological risks of Chinese herbs

Planta Medica

Volumn 76, Issue 17, 2010, Pages 2012-2018

  Shaw, Debbie ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Aconitum; Aristolochia; Chinese herbal medicine; Chinese materia medica; toxicity; traditional Chinese medicine

Indexed keywords

ACONITUM EXTRACT; ARISTOLOCHIA FANGCHI EXTRACT; ARISTOLOCHIC ACID; COMFREY EXTRACT; DIOSCOREA BULBIFERA EXTRACT; EPHEDRA SINICA EXTRACT; GLYCYRRHIZA EXTRACT; KAMPO; PLANT EXTRACT; POLYGONUM MULTIFLORUM EXTRACT; UNCLASSIFIED DRUG; XANTHIUM SIBIRICUM EXTRACT; XIAO CHAI HU TANG;

ACUTE KIDNEY FAILURE; ACUTE TOXICITY; ANEMIA; ANOREXIA; ARTHRITIS; ASTHMA; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; CARDIOTOXICITY; CHINESE HERB; CHINESE MEDICINE; CHRONIC TOXICITY; COMA; CONVULSION; COUGHING; DEATH; DIZZINESS; DRUG APPROVAL; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG ISOLATION; DRUG MECHANISM; DRUG MISUSE; DRUG OVERDOSE; DRUG PURITY; DRUG QUALITY; DRUG SAFETY; DRUG STORAGE; DRUG SURVEILLANCE PROGRAM; EDEMA; EXCITABILITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HEART BLOCK; HEART VENTRICLE TACHYCARDIA; HEMATURIA; HEPATITIS; HEPATOMEGALY; HUMAN; HYPOTENSION; INSOMNIA; ISCHEMIA; JAUNDICE; LETHAL DOSE; LIVER CIRRHOSIS; LIVER INJURY; LIVER TOXICITY; LIVER VEIN OBSTRUCTION; MENTAL DISEASE; NAUSEA; NEPHROTOXICITY; NONHUMAN; OLIGURIA; POLYGONUM; POLYGONUM MULTIFLORUM; RESPIRATORY FAILURE; REVIEW; SIDE EFFECT; SINUSITIS; SUDDEN DEATH; TINNITUS; TONIC CLONIC SEIZURE; TORSADE DES POINTES; TOXICOLOGY; URINARY TRACT CARCINOMA; URTICARIA; VEIN OCCLUSION; VOMITING; WHEEZING; XANTHIUM; XANTHIUM SIBIRICUM;

ACONITUM; ADVERSE DRUG REACTION REPORTING SYSTEMS; ARISTOLOCHIA; CHINA; DRUG CONTAMINATION; DRUG TOXICITY; DRUGS, CHINESE HERBAL; EPHEDRA SINICA; HUMANS; JAPAN; LIVER FAILURE; MATERIA MEDICA; MEDICINE, CHINESE TRADITIONAL; SAFETY; TOXICITY TESTS; XANTHIUM;

ACONITUM; ANIMALIA; ARISTOLOCHIA;

EID: 78649908675     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250533     Document Type: Review

References (77)

1. Pharmacopoeia of the People's Republic of China, Vol 1. Beijing Peoples Medical Publishing House 2005
2. Chan K. Chinese medicinal materials and their interface with Western medical concepts. J Ethnopharmacol 2005 96 1-18
3. Wang J, Van der Heijden R, Spruit S, Hankermeier T, Chan K, Van der Greef J, Xu G, Wang M. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J Ethnopharmacol 2009 126 31-41
4. Xu J, Yang Y. Traditional Chinese medicine in the Chinese health care system. Health Policy 2009 90 133-139
5. Leung A Y. Traditional toxicity documentation of Chinese materia medica an overview. Toxicol Pathol 2006 34 319-326
6. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003 52 1361-1371
7. Xue C C., O'Brien K. Modalities of Chinese Medicine. Leung PC A Comprehensive Guide to Chinese Medicine. Singapore World Scientific Publishing Co. Pte. Ltd. 2003 25-26
8. Zhu Y-P. Chinese Materia Medica Chemistry, pharmacology and applications. Amsterdam Harwood Academic Publishers 1998 28-29
9. Bensky D, Clavey S, Stoger E. Chinese herbal medicine materia medica, 3rd edition. Seattle Eastland Press Inc. 2004 714-715 732-733
10. Wong A, Chan C. Review of adverse events related to Chinese medicines in Hong Kong, July 2004-June 2005. Public Health Epidemiol Bull 2005 14 45-51
11. Edwards I R., Aronson J K. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000 356 1255-1259
12. Reginster F, Jadoul M, van Ysersele de Strihou C. Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephrol Dial Transplant 1995 10 157-160
13. Heinrich M, Chan J, Wanke S, Neinhuis C, Simmonds M. Local uses of Aristolochia species and content of nephrotoxic aristolochic acids 1 and 2 a global assessment based on bibliographic sources. J Ethnopharmacol 2009 125 108-144
14. Nortier J, Vanherweghem J L. For patients taking herbal therapy- lessons from aristolochic acid nephropathy. Nephrol Dial Transplant 2007 22 1512-1517
15. CIOMS Working Group III. Good Safety Information Practices. Guidelines for Preparing Core Clinical Safety Information on Drugs. Geneva WHO 1995
16. Liang J Q., Wang L S. General situation on toxicity researches. Zhongguo Zhong Yao Za Zhi 2000 25 56-58
17. Wang Q, Li H, Zhang Z. Causes and countermeasures about adverse reactions of traditional Chinese medicine. Zhong Yao Cai 2001 24 430-433
18. Song W. Adverse reactions of Chinese medicine. Chin J Basic Med Tradit Chin Med 2000 9 66-68
19. Chen Y. Safety monitoring of traditional Chinese medicines in China. Pharmacovigilance of herbal medicine: current state and future directions. Drug Safety 2006 29 352
20. Zeng Z-P, Jiang J-G. Analysis of the adverse reactions induced by natural product-derived drugs. Br J Pharmacol 2010 159 1374-1391
21. Sin J, Chan C. Review of adverse events related to Chinese medicines in Hong Kong, January 2000-June 2004. Public Health Epidemiol Bull 2004 13 60-66
22. Wong A, Chan C. Review of adverse events related to Chinese medicines in Hong Kong, July 2004-June 2005. Public Health Epidemiol Bull 2005 14 45-51
23. Itoh S, Marutani K, Nishijima T, Matsuo S, Itabashi M. Liver injuries induced by herbal medicines, Sho-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995 40 1845-1848
24. Homma M, Oka K, Ikeshima K, Takahashi N, Niitsuma T, Fukuda T, Itoh H. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol 1995 47 687-692
25. Ohnishi N, Okada K, Yoshioka M, Kuroda K, Nagasawa K, Takara K, Yokoyama T. Studies on interactions between traditional herbal and western medicines, effects of Sho-saiko-to (Xiao-Cai-Hu-Tang) on the pharmacokinetics of carbamazepine in rats. Biol Pharm Bull 2002 25 1461-1466
26. Davies E G., Pollock I, Steel H M. Chinese herbs for eczema. Lancet 1991 336 177
27. Kane J A., Kane S P., Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995 36 146-147
28. Perharic L, Shaw D, Leon C, De Smet P A., Murray V S. Possible association of liver damage with the use of Chinese herbal medicine for skin disease. Vet Hum Toxicol 1995 37 562-566
29. Pillans P I. Herbal medicine and toxic hepatitis. NZ Med J 1994 107 432-433
30. Vautier G, Spiller R C. Safety of complementary medicines should be monitored. BMJ 1995 311 633
31. Yoshida E, McLean C, Cheng E S., Blanc P D., Somberg K A., Ferrell L D., Lake J R. Chinese herbal medicine, fulminant hepatitis and liver transplantation. Am J Gastroenterol 1996 19 2647-2648
32. Levi M, Guchelaar H-J, Woerdenbag H J., Zhu Y-P. Acute hepatitis in a patient using a Chinese herbal tea a case report. Pharm World Sci 1998 20 43-44
33. But P P- H., Tomlinson B, Lee K-L. Hepatitis related to the Chinese medicine Shou wu pian manufactured from Polygonum multiflorum. Vet Hum Toxicol 1996 38 280-282
34. Park G J., Ngu J. Acute hepatitis induced by Shou wu pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001 16 115-117
35. Wong D R., Panis B, Hooymans P, De Smet P A., Rosias P P. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr 2005 41 256-258
36. Mazzanti G, Battinelli L, Daniele C, Mastroianni C M., Lichtner M, Coletta S, Constantini S. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann Intern Med 2004 140 W30
37. Cardenas A, Restrepo J, Sierra F, Correa G. Acute hepatitis due to Shen-Min. J Clin Gastroenterol 2006 40 629-632
38. Vanherweghem L J. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 1998 4 9-13
39. Chan T Y. K. Aconite poisoning. Clin Toxicol 2009 47 279-285
40. Singhuber J, Zhu M, Prinz S, Kopp B. Aconitum in traditional Chinese medicine a valuable drug or an unpredictable risk? J Ethnopharmacol 2009 126 18-30
41. Ma H Y., Liu X B., Li N, Yang M. Interaction of aconitine and glycyrrhizic acid by HPLC. Shizhen Guoyi Guoyao 2006 17 208-209
42. Liu W, Song F, Liu Z, Liu S. The chemical study on combination taboo of Radix Aconiti and Pinellia Tuber. Huaxue Tongbao 2008 71 435-438
43. Tomlinson B, Chan T Y. K., Chan J, Critchley J, But P H. Toxicity of complementary therapies: an eastern perspective. J Clin Pharmacol 2000 40 451-456
44. Kolev S T., Leman P, Kite G C., Stevenson P C., Shaw D. Toxicity following accidental ingestion of Aconitum -containing Chinese remedy. Hum Exp Toxicol 1996 15 839-842
45. Obatomi D K., Bach P H. Biochemistry and toxicology of the diterpenoid glycoside atractyloside. Food Chem Toxicol 1998 36 335-346
46. Nortier J L., Vanherweghem J L. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 2002 181 577-580
47. Pozdzik A A., Salmon I J., Debelle F D., Decaestecker D, Van Dend Branden C, Verbeelen D, Deschodt-Lanckman M M., Vanherweghem J-L, Nortier J L. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 2008 73 595-607
48. Lemy A, Wissing K M., Rorive S, Ziotta A, Roumeguere T, Muniz Martinez M C., Decaestecker C, Salmon I, Abramowicz D, Vanherweghem J L., Nortier J. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage arisotolochic acid nephropathy: a case series with 15-year follow up. Am J Kid Dis 2008 51 471-477
49. Kessler D A. Cancer and herbs. N Engl J Med 2000 342 1742-1743
50. International Agency for Research on Cancer (IARC). Some traditional herbal medicines, some mycotoxins naphthalene and styrene. IARC Monographs on the Evaluation of Carcinogenic Risks of Chemical to Humans. Lyon, France IARC 2002 69-128
51. Grollman A P., Morrie Craig A, Ganey P E., Liu Y, Lowenfels A B., Nortier J L., Schaneberg B T., Stegelmeier B L. Aristolochic acid related exposures expert panel report. Available at. http://ntp.niehs.nih.gov/files/ AAPanelReportBSciJustFinal-Rdtd.pdf Accessed March 31, 2010
52. Wu K M., Farrelly J, Upton R, Chen J. Complexities of the herbal nomenclature system in traditional Chinese medicine: lessons learnt from the misuse of Aristolochia -related species and the importance of the pharmaceutical name during botanical drug product development. Phytomedicine 2007 14 273-279
53. Chen J, Chen T. Chinese medical herbology and pharmacology. California Art of Medicine Press, Inc. 2001 36-39
54. Haller C, Benowitz N. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000 343 1833-1838
55. Shekelle P, Hardy M, Morton S, Maglione M, Mojica W, Suttorp M, Rhodes S, Jungvig L, Gagné J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003 289 1537-1545
56. Bjornsson E. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacol Ther 2006 79 521-528
57. Mattocks A R. Chemistry and toxicology of pyrrolizidine alkaloids. New York Academic Press 1986
58. Larrey D, Vial T, Pauwels A, Castot A, Biour M, David M, Michel H. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992 117 129-132
59. Loeper J, Descatoire V, Letteron P, Moulis C, Degott C, Dansette P, Fau D. Hepatotoxicity of germander in mice. Gastroenterology 1994 106 464-472
60. Zhou S, Koh H, Gao Y, Gong Z, Lee E. Herbal bioactivation: the good, the bad and the ugly. Life Sci 2004 74 935-968
61. Anonymous. MHRA raises concerns about safety of Polygonum multiflorum. MHRA Press Release 28 April 2006. Available at. http://www.mhra.gov.uk/ NewsCentre/Pressreleases/CON2023635 Accessed March 31, 2010.[nl]
62. Zhang L, Yang X, Sun Z, Qu Y. Retrospective study of adverse events of Polygonum multiflorum and risk control. Zhongguo Zhong Yao Za Zhi 2009 34 1724-1729
63. Zhang L, Yang X, Deng Y. Evaluation and consideration on safety information abroad of Polygonum multiflorum and its preparations. Zhongguo Zhong Yao Za Zhi 2009 34 2414-2418
64. McRae C A., Agarwal K, Mutimer D, Bassendine M F. Hepatitis associated with Chinese herbs. Eur J Gastroenterol Hepatol 2002 14 559-562
65. Melchart D, Linde K, Hager S, Shaw D, Bauer R, Weidenhammer W. Monitoring of liver enzymes in patients treated with traditional Chinese drugs. Complement Ther Med 1999 7 208-216
66. Al-Khafaji M. Monitoring of liver enzymes in patients on Chinese medicine. J Chin Med 2000 62 6-10
67. Shaw D. Aspects of Chinese herbal medicine with relation to their hepatotoxicity [thesis]. London Kings College 2007
68. Lee C-H, Wang J-D, Chen P-C. Case-crossover study of hospitalisation for acute hepatitis in Chinese herb users. J Gastroenterol Hepatol 2008 23 1549-1555
69. Mantani N, Kogure T, Sakai S, Goto H, Shibahara N, Kita T, Shimada Y, Terssawa K. Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2496 cases between 1979 and 1999: problems of the lymphocyte transformation test as a diagnositic method. Phytomedicine 2002 9 280-287
70. Ikegami F, Sumino M, Fujii Y, Akiba T, Satoh T. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Hum Exp Toxicol 2006 25 481-494
71. Akashi K, Shirahama M, Iwakiri R, Yoshimatsu H, Nagafuchi S, Hayashi J, Ishibashi H. Drug-induced allergic hepatitis caused by glycyrrhizin or extract of licorice root. Acta Hepatol Jpn 1988 1633-1637
72. Sugiyama T, Sugaya T, Chia S. A case of drug-induced allergic hepatitis by glycyrrhizin. Jap J Gastroenterol 1992 89 1633-1637
73. Klier B, Schimmer O. Microsomal metabolism of dictamnine: identification of metabolites and evaluation of their mutagenicity in Salmonella typhimurium. Mutagenesis 1999 14 181-185
74. Bensoussan A, Myers S, Drew A, Whyte I, Dawson A. Development of a Chinese herbal medicine toxicology database. Clin Toxicol 2002 40 159-167
75. Hsieh S-C, Lai J-N, Chen P-C, Chen H-J, Wang J-D. Development of active safety surveillance system for traditional Chinese medicine: an empirical study in treating climacteric women. Pharmacoepidemiol Drug Saf 2006 15 889-899
76. Chen L C., Wang B R., Chu Y C., Tien J H. Drug utilization pattern of Chinese herbal medicines in a general hospital in Taiwan. Pharmacoepidemiol Drug Saf 2005 14 651-657
77. Hsieh S-C, Lai J-N, Lee C-F, Hu F-C, Tseng W-L, Wang J-D. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiol Drug Saf 2008 17 609-619